13F-HR filed by Paradigm Biocapital Advisors LP
Paradigm Biocapital Advisors LP filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 31 holding rows worth $1,473,652,622.
- Accession
- 0001855655-23-000011
- Filer
- CIK 1855655
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 31 entries on the cover page, a total value of $1,473,652,622 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,473,652,622 with VALUE read as dollars as filed, 13F file number 028-21950. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 2,025,480 | $136,051,492 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 261,443 | $128,533,222 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 2,953,122 | $105,958,017 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 7,803,600 | $96,374,460 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 1,638,147 | $75,305,618 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 3,642,307 | $73,173,948 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 1,668,116 | $72,663,133 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 1,384,686 | $71,865,203 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 307,314 | $69,413,013 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 2,178,737 | $64,795,638 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 1,272,279 | $59,771,667 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 3,681,747 | $56,477,999 | dollars as filed | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 2,532,972 | $55,294,779 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 912,497 | $52,714,952 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 1,491,835 | $50,961,084 | dollars as filed | |
| AMBRX BIOPHARMA, INC. SPONSORED ADR | 02290A102 | COM | 3,488,596 | $40,118,854 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 2,390,077 | $34,703,918 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 14,406,782 | $33,567,802 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 3,619,015 | $30,254,965 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 1,142,383 | $27,771,331 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 2,421,743 | $27,728,957 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 2,058,447 | $23,836,816 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 926,432 | $15,100,842 | dollars as filed | |
| CARIBOU BIOSCIENCES INC COM | 142038108 | Stock | 2,944,513 | $14,074,772 | dollars as filed | |
| VOR BIOPHARMA INC | 929033108 | COM | 6,461,467 | $13,698,310 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 1,081,767 | $12,635,039 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 1,212,828 | $11,060,991 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 1,358,709 | $10,054,447 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 329,100 | $5,081,304 | dollars as filed | call |
| AMBRX BIOPHARMA, INC. SPONSORED ADR | 02290A102 | COM | 209,600 | $2,410,400 | dollars as filed | call |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 225,605 | $2,199,649 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001855655-23-000011 | this filing | 2023-11-14 | acceptance time not in the bulk data set |